Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Salto-Tellez
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients With Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy
Cancer immunology research
Cancer Research
Immunology
Related publications
TM4SF1 as a Prognostic Marker of Pancreatic Ductal Adenocarcinoma Is Involved in Migration and Invasion of Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer
British Journal of Cancer
Cancer Research
Oncology
Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer
PLoS ONE
Multidisciplinary
Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
ATPase Inhibitory Factor 1 Is a Potential Prognostic Marker for the Migration and Invasion of Glioma
Oncology Letters
Cancer Research
Oncology
RAD21 Cohesin Overexpression Is a Prognostic and Predictive Marker Exacerbating Poor Prognosis in KRAS Mutant Colorectal Carcinomas
British Journal of Cancer
Cancer Research
Oncology
MicroRNA-153 Acts as a Prognostic Marker in Gastric Cancer and Its Role in Cell Migration And invasion
OncoTargets and Therapy
Oncology
Pharmacology
NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis
Journal of Cancer
Oncology
Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
